Trials / Completed
CompletedNCT01232335
Symbicort Turbuhaler 30/60 Specific Clinical Experience Investigation
Symbicort Turbuhaler 30/60 Specific Clinical Experience Investigation for Long-term Use
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,500 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to confirm the safety profile for long term treatment and maximize doses and the control status on bronchial asthma in daily clinical usage
Conditions
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2013-05-01
- Completion
- 2013-05-01
- First posted
- 2010-11-02
- Last updated
- 2013-05-29
Locations
47 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01232335. Inclusion in this directory is not an endorsement.